Study Shows Chemopreventative Potential of Kava-Derived Compound
Sometimes, the most simple and elegant solution to a problem has already been known for centuries.
University of Minnesota researchers have explored the medicinal capacity of an ancient plant -
Piper methysticum, c
ommonly known as kava. However, concerns about kava being toxic to the liver have resulted in diminished use. Now, a recently published study has found that a specific kava derivative may have potential to combat cancer without causing any damage to liver cells.
get more information about UMINN research programs
by clicking the button below
Read More
Tags:
Midwest,
University of Minnesota,
cancer research,
Minnesota,
University of Minnesota Twin Cities,
Cancer,
BioResearch Product Faire Event,
Minneapolis,
MN,
UMinn,
2016,
lung cancer
Chemical bioengineers find and create bacteria for several different purposes, such as eating chlorine and consuming toxic byproducts of biodiesel plants. A closer look at these bacterial communities undertaken in a study at Washington University in St. Louis shows that there is actually a division of labor between bacterial workers and layabouts.
Read More
Tags:
WashU,
BioResearch Product Faire Event,
MO,
St Louis,
Washington Univsersity St. Louis,
2016
In January 2013, we were blown away by a completely biological robot created at the University of Illinois, Urbana-Champaign. Two years later, the team is making exciting new steps in this unique and next-generation endeavor.
Read More
Tags:
University of Illinois Urbana-Champaign,
Urbana-Champaign,
UIUrbana,
BioResearch Product Faire Event,
IL,
2016
Though it has been over five hundred years since the Black Death devastated the population of Europe, life science researchers today believe that we can learn something about HIV infections by studying the genetic aftermath of the plague.
Read More
Tags:
University of Cincinnati,
BioResearch Product Faire Event,
Cincinnati,
OH,
UCinci,
2016
The University of Pennsylvania in Philadelphia is one of the top research institutions in the world and is continuously expanding its research potential. Last year, the university opened a new Prematurity Research Center with the support of a $10 million donation from the March of Dimes Foundation of Philadelphia. Earlier this year, the university teamed up with the pharmaceutical company Novartis to open a new center on campus dedicated to cancer research, called the Novartis-Penn Center for Advanced Cellular Therapeutics (CACT).
The Center for Advanced Cellular Therapeutics, which is located on the University of Pennsylvania Medical Campus, is a $27 million project that will provide new laboratory and clinical space for physicians and scientists working to develop personalized cellular therapies for cancer treatments.
Read More
Tags:
Northeast,
University of Pennsylvania,
UPenn,
cancer research,
Philadelphia,
BioResearch Product Faire Event,
PA,
2016,
Novartis,
Center for Advanced Cellular Therapeutics,
Cell therapy
Over the past year, the life science research community has endeavored to control fat in response to the obesity epidemic. We’ve seen papers about reducing fat storage capacity and even burning fat at squirrel speed. However, a recent study by the Michigan State University suggests that fat may actually be linked to longevity.
Read More
Tags:
Michigan State University,
BioResearch Product Faire Event,
MI,
East Lansing,
MSU,
2016
Escherichia coli, most commonly referred to as E. coli, is a common form of bacteria found in the environment, foods, and the intestinal tracts of animals. E. coli is very diverse, with some strains being harmless while others can cause a wide range of illnesses, including urinary tract infections, diarrhea, and pneumonia. With hundreds of thousands of deaths caused by E. coli each year, scientists have been diligently working to better understand this bacteria.
Read More
Tags:
Northeast,
Maryland,
MD,
Baltimore,
University of Maryland, Baltimore,
UMDBalt,
BioResearch Product Faire Event,
Front Line event,
2016,
E Coli
Developing a novel cancer-busting drug is only useful if it can actually be administered to the affected area. We saw last July how UIUC researchers are sneaking drugs past the immune system so they don’t get destroyed in transit. Taking the next step, researchers at The Ohio State University are developing a “Trojan horse” that allows drugs to successfully invade leukemia cells.
Read More
Tags:
Ohio State University,
BioResearch Product Faire Event,
Columbus,
OH,
OhStu,
2016
The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.
Read More
Tags:
Washington University St. Louis,
Midwest,
Missouri,
WashU,
heart disease,
Diabetes,
Autism,
BioResearch Product Faire Event,
MO,
St Louis,
NIH funding,
2016,
Centers for Common Disease Genomics,
stroke,
CCDG
Stem cell research has been used to grow tumors at the University of Illinois and grow leukemia cells at the University of Wisconsin. Another study from the University of Wisconsin, Madison shows that we can make a special kind of stem cell known as the master heart cell using the most common of mammalian cells.
Read More
Tags:
WI,
University of Wisconsin Madison,
UWisc,
BioResearch Product Faire Event,
Madison,
2016
